Loading...

Nehal Gupta, PhD

Title(s)Postdoctoral Scholar, Medicine
SchoolSchool of Medicine
Phone415-353-7627
Emailnehal.gupta@ucsf.edu
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Gupta N, Srivastava SK. Atovaquone: An Antiprotozoal Drug Suppresses Primary and Resistant Breast Tumor Growth by Inhibiting HER2/ß-Catenin Signaling. Mol Cancer Ther. 2019 Oct; 18(10):1708-1720. PMID: 31270151.
      View in: PubMed
    2. Gupta N, Gupta P, Srivastava SK. Penfluridol overcomes paclitaxel resistance in metastatic breast cancer. Sci Rep. 2019 Mar 25; 9(1):5066. PMID: 30911062.
      View in: PubMed
    3. Prasad S, Ramachandran S, Gupta N, Kaushik I, Srivastava SK. Cancer cells stemness: A doorstep to targeted therapy. Biochim Biophys Acta Mol Basis Dis. 2019 Feb 26; 165424. PMID: 30818002.
      View in: PubMed
    4. Gupta P, Gupta N, Fofaria NM, Ranjan A, Srivastava SK. HER2-mediated GLI2 stabilization promotes anoikis resistance and metastasis of breast cancer cells. Cancer Lett. 2019 02 01; 442:68-81. PMID: 30409762.
      View in: PubMed
    5. Verma K, Gupta N, Zang T, Wangtrakluldee P, Srivastava SK, Penning TM, Trippier PC. AKR1C3 Inhibitor KV-37 Exhibits Antineoplastic Effects and Potentiates Enzalutamide in Combination Therapy in Prostate Adenocarcinoma Cells. Mol Cancer Ther. 2018 09; 17(9):1833-1845. PMID: 29891491.
      View in: PubMed
    6. Kim CG, Lee H, Gupta N, Ramachandran S, Kaushik I, Srivastava S, Kim SH, Srivastava SK. Role of Forkhead Box Class O proteins in cancer progression and metastasis. Semin Cancer Biol. 2018 06; 50:142-151. PMID: 28774834.
      View in: PubMed